Azitra, Inc.
AMEX: AZTR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Francisco D. Salva
- Employees
- 12
- Headquarters
- Branford, United States
- IPO year
- 2023
- Market cap
- $1.8M
- Website
- https://azitrainc.com
Loading AZTR…
Loading profile data…Frequently asked questions about AZTR
What does Azitra, Inc. (AZTR) do?
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strai...
Where does AZTR trade?
Azitra, Inc. (AZTR) trades on the New York Stock Exchange American.
What sector is AZTR in?
Azitra, Inc. (AZTR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Azitra, Inc.?
Francisco D. Salva is the chief executive officer of Azitra, Inc. (AZTR).
Where is Azitra, Inc. headquartered?
Azitra, Inc. is headquartered in United States.
Does AZTR pay a dividend?
Azitra, Inc. (AZTR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AZTR go public?
Azitra, Inc. (AZTR) completed its initial public offering in 2023.